Teva's Pliva division increases manufacturing capacity by more than 25%

Teva invests more than $100 million in new Croatian plant

ZAGREB, Croatia — Teva Pharmaceutical Industries is investing more than $100 million in its Croatian division for a plant that will make pills mostly for the international market.

Teva subsidiary Pliva said the new plant, in the capital of Zagreb, would considerably increase its production capacities for tablets and capsules. The company said the new plant would increase the annual manufacturing capacity by more than 25%.

"This year has been especially important for us — we are about to complete one of the largest investment cycles in the company's history," Pliva management board president Tihomir Orešković said. "I am glad that Teva is today one of the biggest private investors in Croatia and that its investments in the production facilities in Zagreb and Savski Marof total more than $200 million."

 

Login or Register to post a comment.